You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Refractory myeloid leukemias

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded

Not yet recruiting
  • Refractory Leukemia
  • +4 more
  • STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
  • Dendritic Cell Vaccine
  • Miami, Florida
    University of Miami
Jan 23, 2023

Relapsed/Refractory Leukemias, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia Trial in Kansas City, Cincinnati

Recruiting
  • Relapsed/Refractory Leukemias
  • +4 more
  • Kansas City, Missouri
  • +1 more
Jul 18, 2022

Ex Vivo Drug Sensitivity Testing and Mutation Profiling

Completed
  • Recurrent Childhood Acute Myeloid Leukemia
  • +13 more
    • Miami, Florida
      Nicklaus Children's Hospital
    Jan 18, 2023

    Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blast Phase Chronic Myeloid Leukemia Trial in Worldwide

    Recruiting
    • Acute Myeloid Leukemia
    • +8 more
    • Ghent, Belgium
    • +28 more
    Nov 11, 2022

    Leukemia, Myeloid, Acute, AML Trial in United States (PTC299)

    Terminated
    • Leukemia, Myeloid, Acute
    • AML
    • Aurora, Colorado
    • +16 more
    Jan 18, 2022

    Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in

    Recruiting
    • Recurrent Acute Lymphoblastic Leukemia
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 29, 2022

    Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Neuroblastoma Trial in Worldwide (Idasanutlin, Venetoclax,

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • +3 more
    • Phoenix, Arizona
    • +19 more
    Jan 18, 2023

    PET-CT Imaging in Relapsed/Refractory Acute Leukemias

    Not yet recruiting
    • B Cell
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 4, 2023

      Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with

      Recruiting
      • Acute Leukemia
      • +27 more
      • HSCT with TBI Regimen
      • HSCT with Non-TBI Regimen
      • Minneapolis, Minnesota
        Masonic Cancer Center at University of Minnesota
      Apr 12, 2022

      Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

      Recruiting
      • Acute Myeloid Leukemia Refractory
      • Acute Myeloid Leukemia, in Relapse
      • anti Tim-3/CD123 CAR-T cell therapy
      • Xuzhou, Jiangsu, China
        Kailin Xu
      Nov 4, 2023

      Acute Myeloid Leukemia Trial (Dasatinib)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • (no location specified)
      Sep 20, 2023

      Recurrent Leukemia, Refractory Leukemia Trial in Houston (Decitabine, Tegavivint)

      Recruiting
      • Recurrent Leukemia
      • Refractory Leukemia
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 31, 2022

      Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

      Recruiting
      • Acute Myeloid Leukemia
      • +3 more
      • CD123 targeted CAR-NK cells
      • Taiyuan, Shanxi, China
        Shanxi Bethune Hospital
      Aug 28, 2023

      Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)

      Recruiting
      • Acute Myeloid Leukemia
      • Beijing, Beijing, China
        Peking University People's Hospital
      Jun 23, 2023

      Leukemia, Acute Lymphoblastic, Acute Myeloid Leukemia, Mixed-Lineage Acute Leukemias Trial in Saint-Petersburg (Allogeneic stem

      Completed
      • Leukemia, Acute Lymphoblastic
      • +2 more
      • Allogeneic stem cell transplantation
      • +3 more
      • Saint-Petersburg, Russian Federation
        First Pavlov State Medical University of St. Petersburg
      Nov 19, 2020

      Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)

      Recruiting
      • Acute Myeloid Leukemia Refractory
      • Lyon, France
        Centre Léon Bérard
      Nov 30, 2023

      Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

      Not yet recruiting
      • Acute Myeloid Leukemia, in Relapse
      • Acute Myeloid Leukemia Refractory
      • (no location specified)
      Nov 9, 2023

      Relapsed/Refractory Acute Myeloid Leukemia Trial in Hangzhou (B7-H3 target, CAR gene modified gdT cell injection)

      Recruiting
      • Relapsed/Refractory Acute Myeloid Leukemia
      • B7-H3 target, CAR gene modified gdT cell injection
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital， Zhejiang University School of Med
      Feb 15, 2023

      AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

      Not yet recruiting
      • AML
      • +11 more
      • (no location specified)
      Aug 14, 2023

      Acute Myeloid Leukemia Trial (Sulfasalazine)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • (no location specified)
      Oct 11, 2022

      Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)

      Recruiting
      • Relapsed or Refractory Acute Myeloid Leukemia
      • Taiyuan, Shanxi, China
        Tao Wang
      Feb 9, 2023

      Refractory/Relapse Acute Myeloid Leukemia Trial in Kunming (Venetoclax)

      Recruiting
      • Refractory/Relapse Acute Myeloid Leukemia
      • Kunming, Yunnan, China
        Department of Hematology,920th Hospital of Joint Logistic Suppor
      Mar 28, 2023

      Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Granulocytic Sarcoma Trial in Winston-Salem (drug,

      Not yet recruiting
      • Acute Myeloid Leukemia, in Relapse
      • +2 more
      • CPI 613
      • +3 more
      • Winston-Salem, North Carolina
        Wake Forest Baptist Comprehensive Cancer Center
      May 10, 2023

      Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse Trial in Miami (Bomedemstat,

      Recruiting
      • Acute Myeloid Leukemia
      • +2 more
      • Miami, Florida
        University of Miami
      Dec 22, 2022

      Relapsed/Refractory Acute Myeloid Leukemia Trial in Hefei (gdT cell injection targeting B7-H3 chimeric antigen receptor)

      Recruiting
      • Relapsed/Refractory Acute Myeloid Leukemia
      • gdT cell injection targeting B7-H3 chimeric antigen receptor
      • Hefei, Anhui, China
        PersonGen Anke Cellular Therapeutice Co., Ltd.
      Jan 31, 2023